TABLE 1.
Patient and Disease Characteristics at Time of Radioimmunotherapy (n = 39)
| Characteristic | n or value |
|---|---|
| Age (y) | |
| Median | 54 |
| Range | 33–81 |
| Male sex | 29 (74) |
| Histology | |
| Indolent* | 31 (79) |
| Transformed (diffuse large B cell) | 8 (21) |
| Stage of disease† | |
| I | 4 (11) |
| II | 14 (37) |
| III | 11 (29) |
| IV | 9 (24) |
| Chemotherapy‡ refractory | 22 (56) |
| No. of prior chemotherapy regimens | |
| Median | 1 |
| Range | 1–5 |
| Bone marrow involvement† | |
| 0% | 26 (68) |
| 1%–25% | 12 (32) |
| No. of tumor sites | |
| Median | 3 |
| Range | 1–7 |
| Presence of bulky disease§ | 10 (26) |
| High lactate dehydrogenase | 12 (31) |
30 follicular, 1 marginal zone. Of the patients with follicular lymphoma, 26 were grade 1 or 2 and 4 were grade 3.
1 unknown.
Chemotherapy or rituximab.
At least 1 tumor with diameter more than 7 cm.
Data in parentheses are percentages.